HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lipofundin S
emulsion containing soy bean oil, soy phosphatides & glycerol
Also Known As:
Lipofundin-S
Networked:
8
relevant articles (
0
outcomes,
2
trials/studies)
Bio-Agent Context: Research Results
Pharmaceutical Preparations
Drug Combinations: 5337
Lipofundin S: 8
Organic Chemicals: 133
Alcohols: 595
Sugar Alcohols: 143
Triose Sugar Alcohols: 4
Glycerol: 4398
Lipofundin S: 8
Carbohydrates: 22023
Sugar Alcohols: 143
Triose Sugar Alcohols: 4
Glycerol: 4398
Lipofundin S: 8
Lipids: 114793
Fats: 2399
Dietary Fats: 4289
Unsaturated Dietary Fats: 101
Soybean Oil: 505
Lipofundin S: 8
Unsaturated Fats: 315
Soybean Oil: 505
Lipofundin S: 8
Membrane Lipids: 1591
Phospholipids: 11903
Lipofundin S: 8
Oils: 1493
Plant Oils: 517
Soybean Oil: 505
Lipofundin S: 8
Complex Mixtures: 1906
Biological Products
Plant Preparations: 622
Plant Oils: 517
Soybean Oil: 505
Lipofundin S: 8
Physiological Phenomena
Diet, Food, and Nutrition
Food
Dietary Fats: 4289
Unsaturated Dietary Fats: 101
Soybean Oil: 505
Lipofundin S: 8
Food and Beverages
Food
Dietary Fats: 4289
Unsaturated Dietary Fats: 101
Soybean Oil: 505
Lipofundin S: 8
Related Diseases
1.
Atherosclerosis
01/01/1987 - "
It has been demonstrated by us and other workers that rats receiving I.V. infusions of Lipofundin-S will develop aortic changes indicative of early atherosclerosis.
"
01/01/1992 - "
Based on the fact that both untreated control and Lipofundin-S-induced atherosclerosis was more frequent and generally more advanced in the obese animals than in their respective lean counterparts, it appears that the obese Zucker rat is more susceptible to both spontaneous and hyperlipidemia-induced atherosclerosis than its respective lean littermate.
"
01/01/1992 - "
In order to evaluate the effect of obesity on lipid-induced atherogenesis, we have utilized this same approach in the present study to demonstrate that i.v. infusions of the parenteral lipid emulsion, Lipofundin-S, will induce in the genetically obese Zucker rat and its lean littermate aortic endothelial and myofibroelastic changes indicative of early atherogenesis.
"
01/01/1993 - "
Using our previously characterized rat model of atherogenesis, we demonstrate that the parenteral lipid emulsions, Lipofundin-S and Liposyn, significantly (p < or = 0.05) enhance baseline platelet aggregation.
"
2.
Sclerosis
01/01/1996 - "
Sprague-Dawley male rats were infused i.v. with 20% Lipofundin-S, a triglyceride-rich emulsion shown by us in previous studies to induce early athero-sclerosis and platelet hyperactivity.
"
3.
Obesity
01/01/1992 - "
In order to evaluate the effect of obesity on lipid-induced atherogenesis, we have utilized this same approach in the present study to demonstrate that i.v. infusions of the parenteral lipid emulsion, Lipofundin-S, will induce in the genetically obese Zucker rat and its lean littermate aortic endothelial and myofibroelastic changes indicative of early atherogenesis.
"
4.
Acute Kidney Injury (Acute Renal Failure)
04/01/1984 - "
[Acute renal failure after infusion of lipofundin S].
"
5.
Jaundice (Icterus)
06/19/1999 - "
Although the lipid emulsions are equivalent according to the product specification, the described observation suggests that Lipofundin S and Endolipid cause more icterus than Intralipid, possibly caused bij an impurity in the fat emulsion.
"
Related Drugs and Biologics
1.
Emulsions
2.
Lipids
3.
Triglycerides (Triacylglycerol)
4.
phospholipid emulsion soybean oil (Intralipid)
5.
lecithin emulsion soybean oil safflower oil